| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/27/2000 | CA2347062A1 Multiple domain glycoprotein hormones and methods of using |
| 04/27/2000 | CA2346798A1 Novel neuropilin/growth factor binding and uses thereof |
| 04/27/2000 | CA2346717A1 Detection and quantification of vancomycin in biological fluids |
| 04/27/2000 | CA2346264A1 Glypicans for the detection and treatment of human carcinoma |
| 04/27/2000 | CA2344605A1 G-protein coupled receptors |
| 04/26/2000 | EP0995798A1 Transcription factor of MHC class II genes, substances capable of inhibiting this new transcription factor and medical uses of these substances |
| 04/26/2000 | EP0995445A2 Ligand-mediated immunofunctional hormone binding protein assay method |
| 04/26/2000 | EP0995121A1 C-peptide specific assay procedure |
| 04/26/2000 | EP0994966A1 Member of the tnf family useful for treatment and diagnosis of disease |
| 04/26/2000 | EP0994951A1 Polynucleotides and their use for detecting resistance to streptogramin a or to streptogramin b and related compounds |
| 04/26/2000 | EP0994947A1 Mu-1, member of the cytokine receptor family |
| 04/26/2000 | EP0994946A1 Coding sequence haplotypes of the human brca2 gene |
| 04/26/2000 | EP0994904A2 AMINO ACID SEQUENCES FOR THERAPEUTICAL AND PROPHYLACTIC APPLICATIONS TO DISEASES DUE TO $i(CLOSTRIDIUM DIFFICILE) TOXINS |
| 04/26/2000 | EP0994903A1 Methods and compositions for galactosylated glycoproteins |
| 04/26/2000 | EP0994900A1 Semaphorin receptors |
| 04/26/2000 | EP0994728A1 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof |
| 04/26/2000 | EP0994724A1 Methods and compositions for impairing multiplication of hiv-1 |
| 04/26/2000 | EP0994720A1 Use of bromelain in the manufacture of a medicament for enhancement of intestinal permeability |
| 04/26/2000 | EP0925305B1 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity |
| 04/26/2000 | EP0925304B1 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism |
| 04/26/2000 | EP0871887A4 Electrochemiluminescent enzyme immunoassay |
| 04/26/2000 | EP0789716B1 Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof |
| 04/26/2000 | EP0656945B1 Stress protein epitopes |
| 04/26/2000 | EP0656013B1 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus |
| 04/26/2000 | EP0579802B1 Bicycle-polyazamacrocyclocarboxylic acid complexes, conjugates, preparation and use as contrast agents |
| 04/26/2000 | CN1251611A USPA1 and USPA2 antigens of moraxelia catarrhalis |
| 04/26/2000 | CN1251610A Novel mouse CXC chemokine receptor |
| 04/26/2000 | CN1251390A Human guanosine monophophate reductase and its coding sequence and preparation method |
| 04/25/2000 | US6054632 Method of making monoclonal antibodies using polymorphic transgenic animals |
| 04/25/2000 | US6054572 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
| 04/25/2000 | US6054567 Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 04/25/2000 | US6054561 Antigen-binding sites of antibody molecules specific for cancer antigens |
| 04/25/2000 | US6054560 Mitogen activated protein kinase, FRK |
| 04/25/2000 | US6054559 Interleukin-1 receptor antagonist beta (IL-1raβ) |
| 04/25/2000 | US6054438 Nucleic acid fragments encoding portions of the core protein of the human mammary epithelial mucin |
| 04/25/2000 | US6054321 Forming three-dimensional structure of a fluorescent protein, constructing model of other fluorescent protein using first as template, making mutants by replacing amino acid(s) within 5 angstroms of any atom of chromophore |
| 04/25/2000 | US6054313 For diagnosis of persistant hyperinsulinemic hypoglycemia of infancy; for screening drugs and antidiabetic agents; for gene therapy |
| 04/25/2000 | US6054303 Cyclosporins conjugated at an alanine nitrogen atom to an immunogenic carrier, a ligand, a small organic compound or a label through a linker of alkylene oxide chain or carbonyloxybenzyl group including 1-3 carboxamide groups |
| 04/25/2000 | US6054297 Preparing humanized immunoglobulin from complimentarity and human framework region; obtaining human and mammalian variable domain sequences, detecting, replacing, and adjusting sequences, detect binding, prepare immunoglobulin |
| 04/25/2000 | US6054296 66 kDa antigen from Borrelia |
| 04/25/2000 | US6054293 Polypeptide involved in chemotatic response; screening for modulator proteins involved in nerve cell migration |
| 04/25/2000 | US6054292 T-cell receptor protein |
| 04/25/2000 | US6054284 Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) GP120 and methods of use |
| 04/25/2000 | US6054273 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 04/25/2000 | US6054132 A purified toxin in diagnostic testing for detecting peptic ulceration and gastric malignancy, and as a vaccine for providing immunologic protection against bacterial infection |
| 04/25/2000 | US6054126 A synthetic polypeptide containing the conformational epitope recognized by monoclonal antibody mab 17-82 for neutralizing antibodies in an avian host; stimulating an immune response against infectious bursal disease virus in poultry |
| 04/25/2000 | US6054124 A milk or a polypeptide subfraction of milk obtained from the allergen treated host, for preventing or alleviating allergic reactions |
| 04/25/2000 | CA1340977C Scavenger receptor protein and antibody thereto |
| 04/25/2000 | CA1340970C Lipase from gastric mucosa |
| 04/22/2000 | CA2285749A1 Novel proteins from actinobacillus pleuropneumoniae |
| 04/20/2000 | WO2000022430A2 Neisseria genomic sequences and methods of their use |
| 04/20/2000 | WO2000022156A1 Antibody against glycerylaldehyde-3-phosphate dehydrogenase and utilization thereof |
| 04/20/2000 | WO2000022144A2 Means and methods for modulating stomata characteristica in plants |
| 04/20/2000 | WO2000022143A2 Protein kinase homologs |
| 04/20/2000 | WO2000022142A2 Cell signaling polypeptides and nucleic acids |
| 04/20/2000 | WO2000022140A1 NUCLEIC ACID MOLECULES WHICH CODE A BRANCHING ENZYME FROM BACTERIA OF THE GENUS NEISSERIA, AND A METHOD FOR PRODUCING α-1,6-BRANCHED α-1,4-GLUCANS |
| 04/20/2000 | WO2000022130A2 Metastatic breast and colon cancer regulated genes |
| 04/20/2000 | WO2000022126A1 Follistatin-related protein zfsta2 |
| 04/20/2000 | WO2000022121A2 Ion channels, in particular vanilloid receptor-like (vr-l) receptor |
| 04/20/2000 | WO2000022120A1 (mbp1) polypeptides capable of interacting with oncogenic mutants of the p53 protein |
| 04/20/2000 | WO2000022111A1 Method for generating diversity |
| 04/20/2000 | WO2000022000A1 Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites |
| 04/20/2000 | WO2000021988A2 Human ankyrin family protein |
| 04/20/2000 | WO2000021986A2 Matrix-remodeling genes |
| 04/20/2000 | WO2000021976A1 Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods |
| 04/20/2000 | WO2000021560A1 Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY |
| 04/20/2000 | WO2000021559A2 Blocking factor b to treat complement-mediated immune disease |
| 04/20/2000 | WO2000021558A1 Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway |
| 04/20/2000 | WO2000021557A1 Delta 6 fatty acid desaturase |
| 04/20/2000 | WO2000021553A2 Method of regulating smn gene expression |
| 04/20/2000 | WO2000021550A2 Methods and compositions for treating neurodegenerative diseases |
| 04/20/2000 | WO2000021544A1 Ups (undecaprenyl diphosphate synthase) |
| 04/20/2000 | WO2000008463A3 Immunoadsorber for removing endotoxins |
| 04/20/2000 | WO2000006605A9 Heterominibodies |
| 04/20/2000 | WO2000004864A3 Agents that bind to and inhibit human cytochrome |
| 04/20/2000 | WO2000004861A3 Agents that bind to and inhibit human cytochrome p450 2a6 |
| 04/20/2000 | WO2000004052A3 Soluble derivatives of anti-angiogenic peptides |
| 04/20/2000 | WO2000003687A3 Potassium channel polypeptide and polynucleotide compositions |
| 04/20/2000 | WO2000001713A9 Diacylglycerol acyl transferase proteins |
| 04/20/2000 | WO2000000622A3 Human oxidoreductase proteins |
| 04/20/2000 | WO1999064626A8 Probes used for genetic profiling |
| 04/20/2000 | WO1999064461A3 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 04/20/2000 | WO1999064000A9 Novel therapeutic agents that modulate neurokinin receptors |
| 04/20/2000 | WO1999061469A3 Prostate growth-associated membrane proteins |
| 04/20/2000 | WO1999060986A3 Apoptosis modulators that interact with the huntington's disease gene |
| 04/20/2000 | WO1999057266A3 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction) |
| 04/20/2000 | WO1999054463A3 Human k+ ion channel and therapeutic applications thereof |
| 04/20/2000 | WO1999053062A3 Isolated sh3 genes associated with myeloproliferative disorders and leukemia, and uses thereof |
| 04/20/2000 | DE19846011A1 Purification of granulocyte preparations useful for transfusion comprises removing nonfunctional granulocytes |
| 04/20/2000 | CA2675802A1 Use of an immunoglobulin-producing cell line to gererate diversity in a gene or gene product |
| 04/20/2000 | CA2347968A1 Follistatin-related protein zfsta2 |
| 04/20/2000 | CA2347653A1 Novel cell signaling polypeptides and nucleic acids |
| 04/20/2000 | CA2347121A1 (mbp1) polypeptides capable of interacting with oncogenic mutants of the p53 protein |
| 04/20/2000 | CA2347113A1 Human ankyrin family protein |
| 04/20/2000 | CA2346775A1 Protein kinase homologs |
| 04/20/2000 | CA2346713A1 Neisseria genomic sequences and methods of their use |
| 04/20/2000 | CA2346259A1 Means and methods for modulating stomata characteristica in plants |
| 04/20/2000 | CA2346006A1 Delta 6 fatty acid desaturase |
| 04/20/2000 | CA2345904A1 Nucleic acid molecules encodeing a branching enzyme from bacteria of the genus neisseria as well as methods for the production of .alpha.-1,6-branched .alpha.-1,4-glucans |
| 04/20/2000 | CA2345885A1 Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods |